Olr808 inhibitors represent a specialized class of chemical compounds designed to specifically target and modulate the activity of the Olr808 receptor. These inhibitors are characterized by their ability to bind to the Olr808 receptor, thereby blocking or reducing its natural activity. The Olr808 receptor, a member of the olfactory receptor family, plays a crucial role in signal transduction pathways, particularly those involved in olfaction. By inhibiting this receptor, researchers can better understand the underlying mechanisms of olfactory perception and the broader implications of olfactory receptor signaling in various biological processes. Structurally, Olr808 inhibitors often exhibit diverse chemical frameworks, including both small organic molecules and more complex synthetic derivatives, designed to achieve high affinity and specificity for the Olr808 receptor.
The development of Olr808 inhibitors involves intricate processes of chemical synthesis, optimization, and validation. Researchers employ a range of techniques such as high-throughput screening, computational modeling, and structure-activity relationship (SAR) studies to identify and refine compounds with the desired inhibitory properties. These inhibitors serve as valuable tools in biochemical and molecular biology research, providing insights into receptor function, ligand-receptor interactions, and receptor-mediated cellular responses. Advanced analytical methods, including mass spectrometry, nuclear magnetic resonance (NMR) spectroscopy, and X-ray crystallography, are often utilized to elucidate the binding interactions and structural conformations of Olr808 inhibitors. Through these detailed studies, scientists aim to uncover the fundamental principles governing olfactory receptor activity and their broader biological significance.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING | 
|---|---|---|---|---|---|---|
Amiodarone | 1951-25-3 | sc-480089 | 5 g | $312.00 | ||
Potassium channel blocker, can modulate cellular ion channels, potentially impacting Olr808 activity.  | ||||||
Candesartan | 139481-59-7 | sc-217825 sc-217825B sc-217825A  | 10 mg 100 mg 1 g  | $46.00 $92.00 $148.00  | 6 | |
Angiotensin II receptor blocker, might affect signaling related to cardiovascular function, impacting Olr808.  | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A  | 100 mg 1 g 5 g  | $76.00 $82.00 $367.00  | 36 | |
Glucocorticoid, could alter inflammatory and immune signaling pathways, impacting Olr808.  | ||||||
Ezetimibe | 163222-33-1 | sc-205690 sc-205690A  | 25 mg 100 mg  | $94.00 $236.00  | 12 | |
Cholesterol absorption inhibitor, may modulate lipid metabolism pathways, affecting Olr808.  | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $40.00 | 9 | |
PPAR alpha agonist, can influence lipid metabolism and signaling, potentially impacting Olr808.  | ||||||
Hydrochlorothiazide | 58-93-5 | sc-207738 sc-207738A sc-207738B sc-207738C sc-207738D  | 5 g 25 g 50 g 100 g 250 g  | $54.00 $235.00 $326.00 $551.00 $969.00  | ||
Diuretic, could modulate fluid balance and electrolyte pathways, impacting Olr808.  | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B  | 10 mg 100 mg 1 g  | $25.00 $117.00 $209.00  | 27 | |
Tyrosine kinase inhibitor, may influence cell growth and apoptosis pathways, affecting Olr808.  | ||||||
Losartan | 114798-26-4 | sc-353662 | 100 mg | $127.00 | 18 | |
Angiotensin II receptor blocker, can modulate cardiovascular signaling pathways, impacting Olr808.  | ||||||
Nateglinide | 105816-04-4 | sc-394067 sc-394067A  | 10 mg 25 mg  | $188.00 $260.00  | ||
Meglitinide, might affect insulin secretion and glucose regulation, impacting Olr808.  | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $66.00 | 4 | |
Proton pump inhibitor, could alter gastric acid secretion pathways, impacting Olr808.  | ||||||